136 related articles for article (PubMed ID: 34343702)
21. Current concepts regarding the HTLV-1 receptor complex.
Ghez D; Lepelletier Y; Jones KS; Pique C; Hermine O
Retrovirology; 2010 Nov; 7():99. PubMed ID: 21114861
[TBL] [Abstract][Full Text] [Related]
22. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.
Jones KS; Fugo K; Petrow-Sadowski C; Huang Y; Bertolette DC; Lisinski I; Cushman SW; Jacobson S; Ruscetti FW
J Virol; 2006 Sep; 80(17):8291-302. PubMed ID: 16912281
[TBL] [Abstract][Full Text] [Related]
23. Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1.
Parker MW; Xu P; Li X; Vander Kooi CW
J Biol Chem; 2012 Mar; 287(14):11082-9. PubMed ID: 22318724
[TBL] [Abstract][Full Text] [Related]
24. Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1.
Jin Q; Alkhatib B; Cornetta K; Alkhatib G
Virology; 2010 Jan; 396(2):203-12. PubMed ID: 19913864
[TBL] [Abstract][Full Text] [Related]
25. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
26. New Crystal Form of Human Neuropilin-1 b1 Fragment with Six Electrostatic Mutations Complexed with KDKPPR Peptide Ligand.
Goudiaby I; Malliavin TE; Mocchetti E; Mathiot S; Acherar S; Frochot C; Barberi-Heyob M; Guillot B; Favier F; Didierjean C; Jelsch C
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513474
[TBL] [Abstract][Full Text] [Related]
27. Distinctive receptor binding properties of the surface glycoprotein of a natural feline leukemia virus isolate with unusual disease spectrum.
Bolin LL; Chandhasin C; Lobelle-Rich PA; Albritton LM; Levy LS
Retrovirology; 2011 May; 8():35. PubMed ID: 21569491
[TBL] [Abstract][Full Text] [Related]
28. Characterization of envelope glycoprotein mutants for human T-cell leukemia virus type 1 infectivity and immortalization.
Tsukahara T; Wielgosz MM; Ratner L
J Virol; 2001 Oct; 75(19):9553-9. PubMed ID: 11533220
[TBL] [Abstract][Full Text] [Related]
29. Structural basis for the binding of the cancer targeting scorpion toxin, ClTx, to the vascular endothelia growth factor receptor neuropilin-1.
Sharma G; Braga CB; Chen KE; Jia X; Ramanujam V; Collins BM; Rittner R; Mobli M
Curr Res Struct Biol; 2021; 3():179-186. PubMed ID: 34401749
[TBL] [Abstract][Full Text] [Related]
30. Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.
Haynes RA; Phipps AJ; Yamamoto B; Green P; Lairmore MD
Viral Immunol; 2009 Dec; 22(6):397-405. PubMed ID: 19951176
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein.
Jinno A; Haraguchi Y; Shiraki H; Hoshino H
J Virol; 1999 Nov; 73(11):9683-9. PubMed ID: 10516085
[TBL] [Abstract][Full Text] [Related]
32. Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus.
Kim FJ; Seiliez I; Denesvre C; Lavillette D; Cosset FL; Sitbon M
J Biol Chem; 2000 Aug; 275(31):23417-20. PubMed ID: 10851227
[TBL] [Abstract][Full Text] [Related]
33. Identification of new genetic subtypes of human T cell leukemia virus type I in Gabon from encoding sequence of surface envelope glycoprotein.
Moynet D; Cosnefroy JY; Bedjabaga I; Roelants G; Georges-Courbot MC; Guillemain B
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1407-11. PubMed ID: 8573399
[No Abstract] [Full Text] [Related]
34. Properties of the naturally occurring soluble surface glycoprotein of ecotropic murine leukemia virus: binding specificity and possible conformational change after binding to receptor.
Ikeda H; Kato K; Suzuki T; Kitani H; Matsubara Y; Takase-Yoden S; Watanabe R; Kitagawa M; Aizawa S
J Virol; 2000 Feb; 74(4):1815-26. PubMed ID: 10644355
[TBL] [Abstract][Full Text] [Related]
35. Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin-1.
Mota F; Yelland T; Hutton JA; Parker J; Patsiarika A; Chan AWE; O'Leary A; Fotinou C; Martin JF; Zachary IC; Djordjevic S; Frankel P; Selwood DL
Chembiochem; 2022 Jan; 23(1):e202100463. PubMed ID: 34647407
[TBL] [Abstract][Full Text] [Related]
36. A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity.
Delamarre L; Rosenberg AR; Pique C; Pham D; Dokhélar MC
J Virol; 1997 Jan; 71(1):259-66. PubMed ID: 8985345
[TBL] [Abstract][Full Text] [Related]
37. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
[TBL] [Abstract][Full Text] [Related]
38. Neuropilin-1 Acts as a Receptor for Complement Split Products.
Battin C; De Sousa Linhares A; Paster W; Isenman DE; Wahrmann M; Leitner J; Zlabinger GJ; Steinberger P; Hofer J
Front Immunol; 2019; 10():2209. PubMed ID: 31572401
[TBL] [Abstract][Full Text] [Related]
39. Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.
Rosenberg AR; Delamarre L; Preira A; Dokhélar MC
J Virol; 1998 Sep; 72(9):7609-14. PubMed ID: 9696862
[TBL] [Abstract][Full Text] [Related]
40. Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans.
Morozov VA; Lagaye S; Taylor GP; Matutes E; Weiss RA
J Virol; 2000 May; 74(9):3933-40. PubMed ID: 10756004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
